These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 3988555)
41. Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Problems of omission in communications. Mosteller F Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):761-4. PubMed ID: 373970 [No Abstract] [Full Text] [Related]
42. Leaving therapy to chance. Marquis D Hastings Cent Rep; 1983 Aug; 13(4):40-7. PubMed ID: 6629749 [TBL] [Abstract][Full Text] [Related]
43. Informed consent. "Blanket" consent to trials would be a good idea. Brewin T BMJ; 1997 Jul; 315(7102):253. PubMed ID: 9253296 [No Abstract] [Full Text] [Related]
45. Randomised trials and informed consent. Brahams D Lancet; 1988 Oct; 2(8618):1033-4. PubMed ID: 2902486 [TBL] [Abstract][Full Text] [Related]
46. Impact of multiple comparisons in randomized clinical trials. Smith DG; Clemens J; Crede W; Harvey M; Gracely EJ Am J Med; 1987 Sep; 83(3):545-50. PubMed ID: 3661589 [TBL] [Abstract][Full Text] [Related]
47. The ethics of the randomized clinical trial. Schafer A N Engl J Med; 1982 Sep; 307(12):719-24. PubMed ID: 7110223 [No Abstract] [Full Text] [Related]
48. Statistical inference and the design of clinical trials. Berry DA Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380 [TBL] [Abstract][Full Text] [Related]
49. Research plan for radiation oncology--1987: design and analysis of clinical trials. Davis LW; Bauer M Am J Clin Oncol; 1988 Jun; 11(3):404-10. PubMed ID: 3381761 [No Abstract] [Full Text] [Related]
50. The randomized controlled clinical trial. Scientific and ethical bases. Spodick DH Am J Med; 1982 Sep; 73(3):420-5. PubMed ID: 7124768 [TBL] [Abstract][Full Text] [Related]
51. An efficient design for phase III studies of combination chemotherapies. Ellenberg SS; Eisenberger MA Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093 [No Abstract] [Full Text] [Related]
54. A new design for randomized clinical trials. Zelen M N Engl J Med; 1979 May; 300(22):1242-5. PubMed ID: 431682 [TBL] [Abstract][Full Text] [Related]
55. [Clinical aspects of the practical implementation of therapy studies]. Havemann K; Harms V Internist (Berl); 1982 Apr; 23(4):201-8. PubMed ID: 7045022 [No Abstract] [Full Text] [Related]
56. Antiemetic studies: a methodological discussion. Olver IN; Simon RM; Aisner J Cancer Treat Rep; 1986 May; 70(5):555-63. PubMed ID: 3708607 [TBL] [Abstract][Full Text] [Related]
57. Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. Feinstein AR J Clin Epidemiol; 1989; 42(6):481-9; discussion 499-502. PubMed ID: 2661727 [No Abstract] [Full Text] [Related]
58. Practical experience of randomization in cancer trials: an international survey. Pocock SJ; Lagakos SW Br J Cancer; 1982 Sep; 46(3):368-75. PubMed ID: 7126426 [TBL] [Abstract][Full Text] [Related]
59. Misunderstandings, mandatory biopsies, and conflicts of interests in clinical trials: a coercive cocktail? McNeil CM; Tattersall MHN Lancet Oncol; 2017 Jul; 18(7):851-852. PubMed ID: 28677563 [No Abstract] [Full Text] [Related]
60. Bayesian and non-Bayesian methods of inference. Small RD; Schor SS Ann Intern Med; 1983 Dec; 99(6):857-9. PubMed ID: 6360005 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]